1. Guidance for industry reports on the status of postmarketing study commitments - implementation of section 130 of the Food and Drug Administration modernization act of 1997 http://www`da.gov/cder/guidance/index.htm
2. The role of databases in drug postmarketing surveillance;Rodriguez;Pharmacoepidemiol Drug Saf,2001
3. US Food and Drug Administration Postmarketing Studies and Clinical Trials-Implementation of Section 505 (o)(3) of the Federal Food, Drug, and Cosmetic Act. FDA/CDER/CBER, Rockville; April 2011. "Postmarketing Studies and Clinical Trials -- Implementation of Section 505 (o)(3) of the Federal Food, Drug, and Cosmetic Act" (PDF-276KB)."
4. Bolstering the FDA's drug-safety authority;Schultz;N Engl J Med,2007